PERSEPT 3 A phase 3 clinical trial to evaluate the haemostatic efficacy of eptacog beta recombinant human FVIIa in perioperative care in subjects with haemophilia A or B with inhibitors

Thumbnail Image

Date

Authors

M Escobar
J Luck
Y Averianov
J Ducore
M Fernandez
Johnny Mahlangu

Journal Title

Journal ISSN

Volume Title

Publisher

Abstract

Description

Keywords

Citation

WOS

Endorsement

Review

Supplemented By

Referenced By